ST中珠 announced that one of its shareholders, Shenzhen Zhongshengyuan Enterprise Management Center (Limited Partnership), plans to reduce its stake by up to 3% of the company's total share capital due to its own capital needs. This reduction will be carried out through centralized bidding and block trading methods. Separately, Weikang Pharmaceutical announced that its product Ganmao Qingre Granules has been selected for a national centralized procurement of traditional Chinese medicine. AI
RANK_REASON The item is a digest of unrelated news items, with no single dominant AI-related story.
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
